erdafitinib,cetrelimab
janssen
['advanced i', 'norse', 'muc ,(-much)']
great abstract rundown from at #asco23 concerning muc advanced in treatment modalities. cross trial analysis must be avoided in muc. chemo + io as 1l is a failed strategy. norse trial shows promising results in fgfra a subpopulation 
#IMG 🇲🇽 / Aspiring Urologist / F1 Enthusiast